Skip to content
PeptideAgent

Telehealth providers in New Hampshire

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in New Hampshire. What New Hampshire requires of telehealth prescribers and pharmacies, plus verified listings.

New Hampshire at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving New Hampshire

No verified telehealth providers serving New Hampshire are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in New Hampshire

RSA 329:1-d provides that an out-of-state physician providing services to a New Hampshire patient by telemedicine is practicing medicine and must be licensed under chapter 329, limits telemedicine prescribing authority to New Hampshire-licensed physicians and physician assistants, and requires all prescribing to comply with state and federal law. For Schedule II through IV controlled drugs, the statute requires a physician-patient relationship and periodic in-person exams, but those rules do not apply to the non-controlled peptides in this database. The statute does not expressly address questionnaire-only asynchronous prescribing, so this record leaves it unconfirmed; the Board of Medicine's standard of care applies. [2]

Compounded GLP-1 access in New Hampshire

A telehealth GLP-1 program serving New Hampshire needs a New Hampshire-licensed prescriber under RSA 329:1-d and a pharmacy with a New Hampshire mail-order registration. [2] [4] [8]

Research use only sellers in New Hampshire

RSA chapter 318 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to New Hampshire consumers are not lawful dispensers in the state. [3] [9]

How to check a telehealth provider in New Hampshire

  1. Confirm the prescriber is licensed or registered to treat patients located in New Hampshire; the telehealth rules above explain what New Hampshire requires. [2]
  2. Ask which pharmacy will fill the prescription and check it in the New Hampshire Board of Pharmacy (Office of Professional Licensure and Certification) license lookup. [1] [3] [4] [5] [6] [7]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Hampshire. [3] [9]

Common questions in New Hampshire

Can an out-of-state doctor treat me in New Hampshire by telemedicine?

Only with a New Hampshire license. RSA 329:1-d treats an out-of-state physician providing telemedicine to a New Hampshire patient as practicing medicine in the state, apart from narrow physician-to-physician consultation. [2]

Can an out-of-state pharmacy ship compounded peptides to me in New Hampshire?

Only if it is registered with the New Hampshire Board of Pharmacy as a mail-order pharmacy under RSA 318:37 and the related provisions. Check the OPLC license lookup before ordering. [1] [4]

All peptide legal questions for New Hampshire

Sources

  1. [1]New Hampshire Board of Pharmacy (OPLC)
  2. [2]New Hampshire RSA 329:1-d, Telemedicine
  3. [3]New Hampshire RSA chapter 318, Pharmacists and pharmacies
  4. [4]New Hampshire RSA 318:37, Mail-order pharmacies: registration required; compliance
  5. [5]New Hampshire Board of Pharmacy laws and rules (Ph 100 to Ph 2600)
  6. [6]N.H. Code Admin. R. Ph 404, Standards for compounding and dispensing sterile and non-sterile pharmaceuticals (in Ph 100 to Ph 2600)
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts